siRNA, Anti-NAP1L3, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT11949WQ-2OMe)

The product SIRGT11949WQ-2OMe is a type of small interfering RNA (siRNA) that targets NAP1L3 gene and regulates the expression of gene. The siRNA interferes with the expression of NAP1L3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_004538.5
Alternative Names MB20; NPL3
Related Diseases X-linked cognitive disability syndromes
Purification HPLC
Target Gene
Gene ID 4675
Uniprot ID Q99457
Sub Cat Target Species Modification Scale  
SIRGT12949WQ-2F NAP1L3 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT13949WQ-2MOE NAP1L3 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT14949WQ-LNA NAP1L3 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT11949WQ-RB NAP1L3 Human Ribo-modified Inquiry
SIRGT12949WQ-BB NAP1L3 Human Backbone-modified Inquiry

Related Products